Evox Therapeutics Limited
Evox Therapeutics Limited is an active company incorporated on 22 March 2016 with the registered office located in . Evox Therapeutics Limited was registered 9 years ago.
Status
Active
Active since incorporation
Company No
10076821
Private limited company
Age
9 years
Incorporated 22 March 2016
Size
Medium
Balance sheet is under £27M
Under 250 employees
Confirmation
Submitted
Dated 16 March 2025 (8 months ago)
Next confirmation dated 16 March 2026
Due by 30 March 2026 (4 months remaining)
Last change occurred 6 months ago
Accounts
Submitted
For period 1 Jan ⟶ 31 Dec 2024 (1 year)
Accounts type is Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (10 months remaining)
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Mr Alexander Eric Hammacher and Alex Eric Hammacher are mutual people.
Active
Mr Alexander Eric Hammacher and Alex Eric Hammacher are mutual people.
Active
Mr Alexander Eric Hammacher and Alex Eric Hammacher are mutual people.
Active
Wallace Lucy Elizabeth Wallace is a mutual person.
Active
Wallace Lucy Elizabeth Wallace is a mutual person.
Active
Brands
Evox Therapeutics is a biotechnology company that develops exosome therapeutics for rare diseases.
Financials
Net Assets, Total Assets & Total Liabilities (2016–2024)
Period Ended
31 Dec 2024
For period 31 Dec ⟶ 31 Dec 2024
Traded for 12 months
Cash in Bank
£21.44M
Decreased by £28.49M (-57%)
Turnover
Unreported
Decreased by £9.22M (-100%)
Employees
58
Decreased by 74 (-56%)
Total Assets
£28.36M
Decreased by £33.28M (-54%)
Total Liabilities
-£2.19M
Decreased by £645K (-23%)
Net Assets
£26.18M
Decreased by £32.63M (-55%)
Debt Ratio (%)
8%
Increased by 3.11% (+68%)
Get Credit Report
Discover Evox Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
